Sjögren’s syndrome is a serious autoimmune disease, though its severity varies widely from person to person. Many people experience it as a manageable condition centered on dryness, but a meta-analysis of existing research found that patients with primary Sjögren’s have roughly a 46% higher risk of death compared to the general population. Between 30% and 90% of patients develop problems beyond dry eyes and mouth, affecting organs like the lungs, kidneys, and nervous system.
The condition is often dismissed as mild because its hallmark symptoms, dryness of the eyes and mouth, sound minor. But Sjögren’s is a systemic disease, meaning the same immune attack that damages moisture-producing glands can target tissue throughout the body. Understanding what can happen beyond dryness is key to taking the disease seriously and catching complications early.
How Sjögren’s Affects the Body Beyond Dryness
The immune system in Sjögren’s attacks epithelial tissue, the type of tissue that lines glands, organs, and blood vessels. This means the disease isn’t confined to tear ducts and salivary glands. It can inflame the kidneys, lungs, nerves, joints, blood vessels, and skin. Doctors call these “extraglandular manifestations,” and they’re far more common than many patients realize. Fatigue is nearly universal and often the most disabling daily symptom, sometimes more so than the dryness itself.
The disease also carries a significantly elevated risk of lymphoma, a type of blood cancer. The lifetime risk of developing non-Hodgkin lymphoma for someone with Sjögren’s is roughly 5% to 10%. One study calculated that patients were about 30 times more likely to develop this cancer compared to the general population. Persistent swelling of the salivary glands, certain blood test abnormalities, and low levels of a blood protein called complement are warning signs that doctors monitor closely.
Nerve Damage and Neurological Problems
Neurological complications affect a substantial number of people with Sjögren’s, with estimates ranging from about 8% to 70% depending on how thoroughly patients are tested. The most common form is peripheral neuropathy, where nerves in the hands and feet are damaged, causing numbness, tingling, burning pain, or loss of sensation. Small fiber neuropathy, which affects the thin nerve endings close to the skin, occurs in an estimated 5% to 10% of patients and can be particularly painful and difficult to diagnose with standard nerve tests.
The autonomic nervous system, which controls things like heart rate, blood pressure, digestion, and sweating, can also be affected. Somewhere between 3% and 50% of patients experience autonomic dysfunction, which might show up as dizziness upon standing, abnormal sweating, digestive problems, or an unusually fast heart rate. Central nervous system involvement, affecting the brain and spinal cord, is less common (2% to 25% of patients) but can cause cognitive difficulties sometimes called “brain fog,” headaches, or in rare cases, symptoms resembling multiple sclerosis.
Lung and Kidney Complications
The lungs are one of the organs most vulnerable to Sjögren’s-related damage. Interstitial lung disease, where inflammation gradually scars the tissue between the air sacs, is the most concerning lung complication. A meta-analysis of patients with Sjögren’s-related interstitial lung disease found a five-year survival rate of about 82% to 88%. Symptoms often start subtly with a persistent dry cough or gradually worsening shortness of breath during physical activity.
Kidney disease in Sjögren’s is more common than many patients and even some doctors expect. Prospective studies that actively looked for kidney involvement found it in 28% to 42% of patients, though rates in routine clinical practice tend to be lower (4% to 7%), likely because mild cases go undetected. The typical kidney problem is tubulointerstitial nephritis, where inflammation damages the tubes inside the kidneys that filter and process urine. This can cause the blood to become too acidic, a condition called renal tubular acidosis, and lead to moderate kidney impairment. Progression to kidney failure is rare but has been reported.
Heart Attack and Stroke Risk
Sjögren’s increases cardiovascular risk in ways that aren’t always obvious. The chronic inflammation driving the disease also affects blood vessels. Studies have found that cerebrovascular events (strokes) occurred in 2.5% of Sjögren’s patients compared to 1.4% of matched controls, and heart attacks occurred in 1.0% versus 0.4%. Over longer follow-up periods, Sjögren’s was associated with a 23% increased risk of heart attack, a 31% increased risk of ischemic stroke, and a 51% increased risk of hemorrhagic stroke. Notably, strokes in Sjögren’s patients occurred at an average age of 55, younger than typical for the general population.
Blood clots are also more common, with a 57% higher risk of venous thromboembolism and a 44% higher risk of peripheral artery disease compared to people without the condition.
The Problem With Delayed Diagnosis
One factor that makes Sjögren’s more dangerous than it needs to be is how long it takes to identify. According to Johns Hopkins Medicine, the average patient waits about three years from the time symptoms first appear to receiving a diagnosis. During that time, organ damage can progress without treatment, and patients often see multiple specialists before someone connects the dots. Dryness, fatigue, and joint pain are common complaints that overlap with many other conditions, which contributes to the delay.
Pregnancy Considerations
Women with Sjögren’s who carry specific antibodies (anti-SSA or anti-SSB, which most Sjögren’s patients have) face a small but real risk during pregnancy. These antibodies can cross the placenta and affect the developing baby, potentially causing neonatal lupus. The most serious complication is congenital heart block, where the baby’s heart develops an abnormal rhythm. This affects fewer than 2% of babies born to mothers who test positive for these antibodies, but it requires close monitoring during pregnancy because it can be permanent and may require a pacemaker after birth.
What Determines Severity
Not everyone with Sjögren’s experiences the same disease. Some people live with bothersome but manageable dryness for decades without major organ involvement. Others develop serious complications within years of their first symptoms. Several factors tend to predict a more severe course: swollen salivary glands that don’t go away, low levels of complement proteins in the blood, the presence of certain antibodies called cryoglobulins, skin rashes involving the blood vessels, and persistently high levels of immune proteins.
The roughly 46% increase in mortality compared to the general population is a population-level statistic, meaning it reflects the full range of disease severity. For patients whose disease stays limited to glandular symptoms, life expectancy is likely close to normal. The increased risk is concentrated among those who develop lymphoma, significant lung disease, or other major organ involvement. Regular monitoring with blood tests and attention to new symptoms can help catch complications when they’re still treatable.